Microscopy

IR Spectroscopy Market worth $1.6 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, April 3, 2024
LWIR, Environmental monitoring, Statistics, PerkinElmer, MCT, Quality control, Shortwave radio, Infrared, Indium gallium arsenide, Monitoring, Indium arsenide, Near, FT, Food, Cooling, Bruker, MWIR, Shimadzu, Agilent Technologies, Countertop, Miniaturization, Mercury cadmium telluride, Security, SWIR, Microscopy

The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029.

Key Points: 
  • The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029.
  • Back Office & Other Services segment accounted for the largest share of ~52% of the IR spectroscopy market in 2029.
  • Europe is expected to hold the second largest share of the IR spectroscopy market during the forecast period.
  • Europe held the second largest share of ~31% in the IR spectroscopy industry in 2029.

IR Spectroscopy Market worth $1.6 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, April 3, 2024
LWIR, Environmental monitoring, Statistics, PerkinElmer, MCT, Quality control, Shortwave radio, Infrared, Indium gallium arsenide, Monitoring, Indium arsenide, Near, FT, Food, Cooling, Bruker, MWIR, Shimadzu, Agilent Technologies, Countertop, Miniaturization, Mercury cadmium telluride, Security, SWIR, Microscopy

The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029.

Key Points: 
  • The healthcare and pharmaceuticals segment accounted for the largest share of ~30% of the IR spectroscopy market in 2029.
  • Back Office & Other Services segment accounted for the largest share of ~52% of the IR spectroscopy market in 2029.
  • Europe is expected to hold the second largest share of the IR spectroscopy market during the forecast period.
  • Europe held the second largest share of ~31% in the IR spectroscopy industry in 2029.

Kemp Proteins and Columbia Biosciences Announce Strategic Partnership for Fluorophore Conjugation Solutions

Retrieved on: 
Tuesday, April 2, 2024
Partnership, Projection screen, Research, Strategic partnership, Protein, Luminex, Antibody, Drug development, Quality management system, Therapy, Microscopy, Vaccine

FREDERICK, Md., April 2, 2024 /PRNewswire-PRWeb/ -- Kemp Proteins LLC, a leading provider of monoclonal antibody development and gene-to-protein services, announced today that the company has entered a Strategic Partnership with Columbia Biosciences of Frederick, Maryland. With a long history in manufacturing of fluorescent proteins and renowned excellence in protein conjugation, Columbia Biosciences uses its experience to select appropriate fluorophores and conjugation chemistries for target antibodies and proteins. Columbia's technology is broadly applicable in the molecular tools and diagnostic space with applications in Flow Cytometry, Luminex, Western Blot/ELISA, Microscopy and High Throughput Screening. The combination of Kemp's capability to develop and manufacture gram quantities of proteins and monoclonal antibodies for its clients, together with Columbia's superior fluorescent conjugation, will provide a streamlined opportunity to generate client-directed, custom-tailored ready-to-use molecular tools manufactured under ISO13485:2016 compliant Quality Management Systems.

Key Points: 
  • FREDERICK, Md., April 2, 2024 /PRNewswire-PRWeb/ -- Kemp Proteins LLC, a leading provider of monoclonal antibody development and gene-to-protein services, announced today that the company has entered a Strategic Partnership with Columbia Biosciences of Frederick, Maryland.
  • With a long history in manufacturing of fluorescent proteins and renowned excellence in protein conjugation, Columbia Biosciences uses its experience to select appropriate fluorophores and conjugation chemistries for target antibodies and proteins.
  • Under the Partnership, Kemp Proteins will utilize its proven monoclonal antibody development and gene-to-protein capabilities to produce, purify and QC the antibodies/proteins for supply to Columbia Biosciences for fluorescent labeling.
  • This strategic partnership will provide turnkey custom solutions for our biopharma, diagnostic and life science clients," said Michael Keefe, CEO for Kemp Proteins.

New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812

Retrieved on: 
Tuesday, February 6, 2024
PLOS One, SNAP, Synapse, CMO, Cognition, Microscopy, FRET, University, Protein, PLOS, Therapy, Brain, Biology, Prion, Translational Neurodegeneration, TMEM97, Doctor of Philosophy, Medical imaging

Results detected TMEM97, a protein component of the σ-2 receptor complex, in close proximity to cellular prion protein (PrPc) on Alzheimer’s brain synapses.

Key Points: 
  • Results detected TMEM97, a protein component of the σ-2 receptor complex, in close proximity to cellular prion protein (PrPc) on Alzheimer’s brain synapses.
  • These findings support the hypothesis that these receptor proteins may form a complex on the synapse surface with Aβ oligomers binding to one or both proteins.
  • “Previous work indicated that Aβ oligomers damage synapses, but until now it was not possible to know which proteins bind toxic forms of Aβ in human synapses.
  • Importantly, this FRET signal is reduced in CT1812-treated mice, suggesting that CT1812 caused the release of Aβ oligomers from their binding site and prevented them from re-binding.

Global Research Antibodies Market Report 2024, Featuring Profiles of Abcam, Thermo Fisher Scientific, Cell Signaling Technology, Merck, Sino Biological & Bio-Rad - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 31, 2024
Biotechnology, Infectious Diseases, Health, Science, Research, Antigen, Growth, Bio-Rad Laboratories, ESG, Fever Dream, Therapy, HIV, Thermo Fisher Scientific, Antibody, FDA, Microscopy, IVD, Abcam, Infection, Flow cytometry, Malaria, Merck Group, Vaccine

The global market for research antibodies was valued at approximately $3.5 billion in 2022.

Key Points: 
  • The global market for research antibodies was valued at approximately $3.5 billion in 2022.
  • Among product segments, the primary antibody segment accounted for the highest market share in the global market for research antibodies in 2022.
  • The advancement of biological discoveries will result in the need for more molecular targets to be detected by their antibodies.
  • This report segments the global market for research antibodies based on type of antibody, clonality, host, major reactivities, application, end user and region.

Kopin Receives Initial Production Order for Advanced Surgical Information Display

Retrieved on: 
Tuesday, January 23, 2024
Wearables, Mobile Technology, Surgery, Health, Technology, Health Technology, 2D, Senior, Instrument, Peter Hancock (professor), Endoscopy, 2-D, CR3, Corporation, Business development, Microscopy, Kopin Corporation, 3D, HMD, Surgeon, KOPN, Medical imaging

Kopin Corporation (NASDAQ: KOPN ), a leading provider of application-specific optical solutions and high performance micro-displays for defense, enterprise, consumer and medical products, today announced it has received an initial production order for the CR3 wearable surgical monitor from HMDmd Inc (HMDmd).

Key Points: 
  • Kopin Corporation (NASDAQ: KOPN ), a leading provider of application-specific optical solutions and high performance micro-displays for defense, enterprise, consumer and medical products, today announced it has received an initial production order for the CR3 wearable surgical monitor from HMDmd Inc (HMDmd).
  • The CR3 provides full-HD resolution 3-D imagery in a lightweight, ergonomic package and is 4K video compatible.
  • The CR3 is configured for use with 2-D and 3-D endoscopes and operating microscopes/exoscopes and is plug-in compatible with products produced by major surgical systems companies.
  • In the development process Kopin's deep experience in the design and production of mission-critical, head-mounted microdisplay systems for the military proved critical.

Exosens Signs Partnership With Scientific Imaging Inc.

Retrieved on: 
Friday, December 1, 2023
USB3 Vision, Partnership, Quality control, LWIR, Microscopy, Knowledge, Imaging, NETD, SWIR, Swap, UV, Indium gallium arsenide

Exosens signs a partnership with Scientific Imaging, Inc. to distribute its two main products brands: Photonis and Xenics.

Key Points: 
  • Exosens signs a partnership with Scientific Imaging, Inc. to distribute its two main products brands: Photonis and Xenics.
  • MERIGNAC, FRANCE, Dec 2, 2023 - (ACN Newswire) - All products from Xenics and Photonis are covered in the distribution and partnership agreement with Scientific Imaging.
  • Scientific Imaging supplies best-in-class imaging solutions for a wide range of applications in Life Sciences, Microscopy, Inspection, Machine Vision and Quality Control.
  • With a team of experienced professionals providing imaging solutions to meet the needs of imaging projects, Scientific Imaging is excited to bring its knowledge and expertise to help develop new sales opportunities with Photonis and Xenics products.

Hexapod Production: PI Substantially Increases Production Capacities for High Precision Hexapod Stewart Platforms

Retrieved on: 
Wednesday, November 29, 2023
Hexapod, PI, Workforce, Microscopy, Fraunhofer Society, Silicon, Semiconductor, Peter Hancock (professor), Silicon photonics, Automation, Nano, Engineering, Photonics, Stewart platform, Freedom

KARLSRUHE, Germany, Nov. 29, 2023 /PRNewswire-PRWeb/ -- Based on a comprehensive analysis of the production processes for hexapods (Stewart Platforms), Physik Instrumente (PI) has adapted its production capacities to the sharp increase in demand and is prepared to expand them even further when required. The focus of the restructuring was the optimization and relocation of PI's entire "Hexapod" micro-robotics production area to newly designed premises, as well as the expansion of the workforce. These measures are an integral part of the company-wide investment program with a volume of close to $70 million. The aim is to capitalize on PI's above-average growth opportunities in markets such as Industrial Automation, Semiconductors, Photonics, Microscopy and Life Sciences.

Key Points: 
  • KARLSRUHE, Germany, Nov. 29, 2023 /PRNewswire-PRWeb/ -- Based on a comprehensive analysis of the production processes for hexapods (Stewart Platforms), Physik Instrumente (PI) has adapted its production capacities to the sharp increase in demand and is prepared to expand them even further when required.
  • The focus of the restructuring was the optimization and relocation of PI's entire "Hexapod" micro-robotics production area to newly designed premises, as well as the expansion of the workforce.
  • The new hexapod production factory layout was developed by PI experts, with the support of specialists from the Fraunhofer Institute for Manufacturing Engineering and Automation IPA.
  • The redesigned factory layout for PI's hexapod production was developed according to the latest ergonomic findings and taking lean principles into account.

The Paul G. Allen Family Foundation awards $10.5 million to new Allen Distinguished Investigators

Retrieved on: 
Tuesday, November 21, 2023
Medicine, Brain, Genetics, Research, Behavior, Reproduction, Hormone, Immune system, Inflammation, Testosterone, Allen Institute, EVS, Immunity, Microscopy, B cell, Disease, Protein, Learning, Mortality, Cardiovascular disease, Glossary of biology, Extracellular vesicle, Lipoprotein, Male, Neuron, Map, Animal, Machine learning, Health, COVID-19, Seminal vesicles, Ageing, Administration, Infection, Estradiol, Mammal, Neuroendocrinology, EV, DSM-IV codes, Skin, Female, Innovation, Cell, Biology, Traffic barrier, Pharmaceutical industry, Vaccine, Fireworks, Birth control, Science

18 researchers will develop technologies, design approaches and uncover insights into fundamental areas of human biology

Key Points: 
  • 18 researchers will develop technologies, design approaches and uncover insights into fundamental areas of human biology
    The Paul G. Allen Family Foundation will award $1.5 million to seven research projects which 18 researchers will lead.
  • "Our two newest cohorts of Allen Distinguished Investigators are using innovative technologies and unprecedented ambition to pioneer new frontiers in the fields of sex hormones and extracellular vesicles.
  • said Kathy Richmond , Ph.D., M.B.A., Executive Vice President and Director of the Frontiers Group and the Office of Science and Innovation at the Allen Institute.
  • Including the new awards, a total of 130 Allen Distinguished Investigators have been appointed during the past 12 years.

Laboratory Testing and PCR Technology Lead the India Infectious Disease Diagnostics Market, Transforming Disease Detection and Management - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 8, 2023
Health, Infectious Diseases, Pathogen, Laboratory, Research, Public health surveillance, RPA, Molecular biology, Infection, Parasitism, Biomarker, Contact tracing, Research and development, CRISPR, PCR, Disease, Sputum, Fungus, Virulence, LAMP, Whole genome sequencing, Artificial intelligence, Vaccination, Urine, NGS, Diagnosis, COVID-19, Medicine, WGS, Blood, Microscopy, Public, Gene expression, DNA, Vaccine, Pharmaceutical industry, Epidemiology

The India emerging infectious disease diagnostics market is set for substantial growth over the forecast period from 2023 to 2033.

Key Points: 
  • The India emerging infectious disease diagnostics market is set for substantial growth over the forecast period from 2023 to 2033.
  • The India emerging infectious disease diagnostics market is currently in an emerging phase.
  • The India emerging infectious disease diagnostics market plays a pivotal role in modern biotechnology, clinical diagnostics, and pathogen research.
  • The India emerging infectious disease diagnostics market is segmented into key categories:
    In FY2022, laboratory testing was the dominant application segment in the India emerging infectious disease diagnostics market.